(Q51005281)

26 March 2018

title

Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta (English)

1 reference

26 March 2018

1 reference

1 reference

Hughes DE

1

1 reference

26 March 2018

Dai A

2

1 reference

26 March 2018

Tiffee JC

3

1 reference

26 March 2018

Li HH

4

1 reference

26 March 2018

Mundy GR

5

1 reference

26 March 2018

Boyce BF

6

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 October 1996

1 reference

26 March 2018

published in

Nature Medicine

1 reference

26 March 2018

volume

2

1 reference

26 March 2018

issue

10

1 reference

26 March 2018

page(s)

1132-1136

1 reference

26 March 2018

Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin

cites work

1 reference

Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype

21 January 2018

1 reference

Continuous c-fos expression precedes programmed cell death in vivo

21 January 2018

1 reference

How many women have osteoporosis now?

21 January 2018

1 reference

7 January 2021

Prevention and treatment of osteoporosis

1 reference

7 January 2021

Estrogens and cell death in murine uterine luminal epithelium.

1 reference

7 January 2021

Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone

1 reference

7 January 2021

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

7 January 2021

Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures

1 reference

7 January 2021

Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function

1 reference

7 January 2021

Isolation and Characterization of Highly Enriched, Prefusion Mouse Osteoclastic Cells

1 reference

7 January 2021

Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta

1 reference

7 January 2021

Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells

1 reference

7 January 2021

Increased osteoclast development after estrogen loss: mediation by interleukin-6

1 reference

7 January 2021

Bone-cell changes in estrogen-induced bone-mass increase in mice: dissociation of osteoclasts from bone surfaces

1 reference

7 January 2021

Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats

1 reference

7 January 2021

Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures

1 reference

7 January 2021

Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria

1 reference

7 January 2021

Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells

1 reference

7 January 2021

Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss

1 reference

7 January 2021

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

1 reference

7 January 2021

Cytokines and estrogen in bone: anti-osteoporotic effects

1 reference

7 January 2021

Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria

1 reference

7 January 2021

Raloxifene preserves bone strength and bone mass in ovariectomized rats

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1096-1132

1 reference

26 March 2018

1 reference

26 March 2018